- PR Newswire•yesterday
Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications
NEW YORK, March 21, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. Ora is the world's leading ophthalmology CRO for advancing products from pre-clinical through approval and post-market phases.
- Motley Fool•2 days ago
Insys Therapeutics has been experiencing a few problems lately that sent its stock price plunging. But its issues are only temporary, and its upsides are anything but.
- Motley Fool•3 days ago
There's a doomsday scenario for GW Pharmaceuticals.
MJNA : Summary for MEDICAL MARIJUANA, I - Yahoo Finance
Medical Marijuana, Inc. (MJNA)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.12 - 0.13|
|52 Week Range||0.03 - 0.27|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||13.66|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|